Format

Send to

Choose Destination
See comment in PubMed Commons below
OMICS. 2012 Jul-Aug;16(7-8):374-86. doi: 10.1089/omi.2011.0127. Epub 2012 Jun 26.

Integrated phospholipidomics and transcriptomics analysis of Saccharomyces cerevisiae with enhanced tolerance to a mixture of acetic acid, furfural, and phenol.

Author information

  • 1Key Laboratory of Systems Bioengineering, Ministry of Education; Department of Pharmaceutical Engineering, School of Chemical Engineering and Technology, Tianjin University , Tianjin, PR China.

Abstract

A mixture of acetic acid, furfural, and phenol (AFP), three representative lignocellulose-derived inhibitors, significantly inhibited the growth and bioethanol production of Saccharomyces cerevisiae. In order to uncover the mechanisms behind the enhanced tolerance of an inhibitor-tolerant S. cerevisiae strain (T), we measured the plasma membrane properties, which significantly influence cellular adaptation to inhibitors, of T strain and its parental strain (P) with and without AFP treatment. We integrated data obtained from multi-statistics-assisted phospholipidomics and parallel transcriptomics by using LC-tandem MS and microarray analysis. With the AFP treatment, the transcriptional changes of fatty acid metabolic genes showed a strong correlation with the increase of fatty-acyl-chain length of phosphatidylcholine (PC) and phosphatidylinositol (PI). This suggests a possible compensatory mechanism to cope with the increase of plasma membrane permeability and fluidity in both strains. Moreover, the absence of phosphatidylserine (PS) and phosphatidylethanolamine (PE) species from the most variable phospholipid species group was a discriminative feature of the T strain. This resulted from the decrease of CHO1 and increase of CHO2 levels of the T strain upon AFP treatment. These novel findings reveal that the coordinated transcription and phospholipid composition changes contribute to the increased robustness of the T strain and highlight potential metabolic engineering targets for mutants with higher tolerance.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Mary Ann Liebert, Inc.
    Loading ...
    Write to the Help Desk